PlainRecalls
FDA Drug Moderate Class II Terminated

oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07

Reported: June 17, 2020 Initiated: May 28, 2020 #D-1302-2020

Product Description

oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07

Reason for Recall

Subpotent drug - Product did not contain drug.

Details

Recalling Firm
QuVa Pharma, Inc.
Units Affected
648 bags
Distribution
USA Nationwide
Location
Sugar Land, TX

Frequently Asked Questions

What product was recalled?
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07. Recalled by QuVa Pharma, Inc.. Units affected: 648 bags.
Why was this product recalled?
Subpotent drug - Product did not contain drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 17, 2020. Severity: Moderate. Recall number: D-1302-2020.